Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Avexis, Inc. (AVXS)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Avexis, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1652923.
Total stock buying since 2015: $14,705,330.
Total stock sales since 2015: $27,211,250.
Total stock option exercises since 2015: $917,331.
Table 3. Detailed insider trading at Avexis, Inc. (AVXS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2018-04-02 | Kaspar Brian K. (Chief Scientific Officer) | Sale | 15,000 | 120.25 | 1,803,705 |
| 2018-04-02 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Sale | 2,000 | 120.22 | 240,446 |
| 2018-04-02 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Option Ex | 2,000 | 18.17 | 36,340 |
| 2018-04-02 | Litalien James J (SrVP/Chief Reg&Quality Officer) | Sale | 5,000 | 120.08 | 600,425 |
| 2018-04-02 | Litalien James J (SrVP/Chief Reg&Quality Officer) | Option Ex | 5,000 | 18.17 | 90,850 |
| 2018-03-07 | Nolan Sean P. (President & CEO) | Sale | 10,000 | 129.21 | 1,292,080 |
| 2018-03-07 | Nolan Sean P. (President & CEO) | Option Ex | 10,000 | 15.94 | 159,400 |
| 2018-03-01 | Kaspar Brian K. (Chief Scientific Officer) | Sale | 15,000 | 125.06 | 1,875,870 |
| 2018-03-01 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Sale | 2,000 | 125.51 | 251,012 |
| 2018-03-01 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Option Ex | 2,000 | 18.17 | 36,340 |
| 2018-03-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 125.50 | 223,397 |
| 2018-03-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2018-02-01 | Kaspar Brian K. (Chief Scientific Officer) | Sale | 15,000 | 119.94 | 1,799,145 |
| 2018-02-01 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Sale | 2,000 | 119.90 | 239,808 |
| 2018-02-01 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Option Ex | 2,000 | 18.17 | 36,340 |
| 2018-02-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 119.54 | 212,784 |
| 2018-02-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2018-01-16 | Litalien James J (SrVP/Chief Reg&Quality Officer) | Sale | 5,000 | 107.47 | 537,335 |
| 2018-01-16 | Litalien James J (SrVP/Chief Reg&Quality Officer) | Option Ex | 5,000 | 18.17 | 90,850 |
| 2018-01-02 | Kaspar Brian K. (Chief Scientific Officer) | Sale | 15,000 | 109.80 | 1,647,000 |
| 2018-01-02 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Sale | 2,000 | 109.49 | 218,980 |
| 2018-01-02 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Option Ex | 2,000 | 18.17 | 36,340 |
| 2018-01-02 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 109.81 | 195,470 |
| 2018-01-02 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-12-04 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Sale | 2,000 | 95.24 | 190,480 |
| 2017-12-04 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Option Ex | 2,000 | 18.17 | 36,340 |
| 2017-12-01 | Kaspar Brian K. (Chief Scientific Officer) | Sale | 15,000 | 94.04 | 1,410,600 |
| 2017-12-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 94.82 | 168,774 |
| 2017-12-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-11-01 | Kaspar Brian K. (Chief Scientific Officer) | Sale | 15,000 | 102.16 | 1,532,385 |
| 2017-11-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 102.37 | 182,220 |
| 2017-11-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-10-09 | Kaspar Brian K. (Chief Scientific Officer) | Sale | 15,000 | 102.09 | 1,531,425 |
| 2017-10-02 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 97.77 | 174,021 |
| 2017-10-02 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-09-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 93.42 | 166,287 |
| 2017-09-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-08-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 91.97 | 163,706 |
| 2017-08-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-07-03 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 82.04 | 146,031 |
| 2017-07-03 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-06-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 71.10 | 126,557 |
| 2017-06-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-05-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,780 | 81.87 | 145,723 |
| 2017-05-01 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,780 | 18.47 | 32,876 |
| 2017-04-03 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Sale | 1,781 | 76.13 | 135,587 |
| 2017-04-03 | Nagendran Sukumar (Sr. VP & Chief Medical Officer) | Option Ex | 1,781 | 18.47 | 32,895 |
| 2016-09-13 | Manning Paul B (Director) | Sale | 289,855 | 34.50 | 9,999,997 |
| 2016-02-17 | Deerfield Private Design Fund Iii, L.p. | Buy | 486,495 | 20.00 | 9,729,900 |
| 2016-02-10 | Knudten Andrew F. (SrVP/Manufacture&Supply Chain) | Buy | 5,000 | 20.00 | 100,000 |
| 2015-09-03 | Deerfield Private Design Fund Iii, L.p. | Buy | 263,822 | 18.48 | 4,875,430 |
Insider trading activities including stock purchases, stock sales, and option exercises
of AVXS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Avexis, Inc. (symbol AVXS,
CIK number 1652923) see
the Securities and Exchange Commission (SEC) website.